Tech Company Financing Transactions
Colossal Biosciences Funding Round
On 9/17/2025, Colossal Biosciences raised $120 million in financing from private investors and US Innovative Technology Fund.
Transaction Overview
Company Name
Announced On
9/17/2025
Transaction Type
Venture Equity
Amount
$120,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Dallas, TX Undisclosed
USA
Dallas, TX Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Colossal Biosciences, we endeavor to jumpstart nature's ancestral heartbeat. To see the Woolly Mammoth thunder upon the tundra once again. To advance the economies of biology and nutrition. To make humanity more human. And to reawaken the lost wilds of Earth. So we, and our planet, can breathe easier.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Kent Wakeford
Co-Founder
Brian Beard
Co-Founder
Andrew Busey
Co-Founder
Peter Phillips
Founder
George Church
Founder
Ben Lamm
Browse more venture capital transactions:
Prev: 9/17/2025: Ultralytics venture capital transaction
Next: 9/17/2025: Trially AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs